Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-08

Clinical Trial Update: Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of HU007 eye drops in patients with Dry Eye Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HU007

Snippet

Sponsor: Huons Co., Ltd. | Conditions: Dry Eye Syndrome | Phase 3 | Status: COMPLETED